beta-lactams has been researched along with Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.68) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 15 (48.39) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Ainekulu, Z; Bhat, A; Bradshaw, CW; Del Rosario, J; Desharnais, J; Doppalapudi, VR; Hagen, C; Huang, J; Jin, P; Lai, JY; Lappe, RW; Lerner, RA; Levin, NJ; Li, L; Liu, B; Liu, D; Matin, MJ; Murphy, RE; Oates, BD; Parish, M; Shields, MJ; Woodnutt, G | 1 |
| Alves, AJS; Alves, NG; Bela Sarmento-Ribeiro, A; Cristina Gonçalves, A; Filomena Botelho, M; Gomes, CSB; Laranjo, M; Pinho E Melo, TMVD | 1 |
| Horita, N; Kaneko, T; Namkoong, H; Shibata, Y; Watanabe, H | 2 |
| Akbarizadeh, AR; Batta, G; Behzadi, M; Borazjani, N; Brunel, JM; Digiorgio, C; Ghanbari, MM; Ghasemi, Y; Jarrahpour, A; Mohkam, M; Rad, JA; Sasanipour, M; Sepehri, S; Turos, E | 1 |
| Dickstein, Y; Grozinsky-Glasberg, S; Leibovici, L; Paul, M; Schlesinger, A; Soares-Weiser, K | 1 |
| Hiemenz, JW; Klinker, K; McCullough, BJ; Richards, A; Wiggins, LE; Wingard, JR | 1 |
| Bodro, M; Boix, L; Calvo, M; Carratalà, J; Contra, A; Domingo-Domenech, E; Garcia-Vidal, C; Gudiol, C; Tubau, F | 1 |
| Chemaly, RF; Mahajan, SN; Nesher, L; Rolston, KV; Tverdek, FP | 1 |
| Bruno, JJ; Dee, BM; Qiao, W; Smith, ZR; Tajchman, SK; Tverdek, FP | 1 |
| Carraro, F; Caselli, D; Castagnola, E; Cesaro, S; Colombini, A; Fagioli, F; Meazza, C; Zanazzo, G; Ziino, O | 1 |
| Contreras, V; Heredia, A; Sepúlveda, S | 1 |
| Iguchi, A; Kaneda, M; Kobayashi, R; Nakajima, M; Sato, T | 1 |
| Andresen, D; Burbury, K; Dawson, L; Kelly, A; Lingaratnam, S; O'Reilly, M; Slavin, MA; Tam, CS; Thursky, KA; Turnidge, J; Worth, LJ | 1 |
| Kirkpatrick, CM; Lipman, J; Mohd Hafiz, AA; Roberts, JA; Staatz, CE | 1 |
| Al Akhrass, F; Chaftari, AM; Chandra, J; Ghannoum, M; Hachem, R; Haydoura, S; Kontoyiannis, DP; Mohamed, JA; Raad, I; Tarrand, J | 1 |
| Brhelova, E; Cizek, A; Dobiasova, H; Dolejska, M; Dubska, L; Jurankova, J; Krivdova, J; Kutnikova, L; Literak, I; Sevcikova, A; Sterba, J; Vavrina, M | 1 |
| Grozinsky, S; Leibovici, L; Paul, M; Soares-Weiser, K | 2 |
| Bhuiyan, M; Chen, D; Coates, C; Daniel, K; Dou, QP; Kazi, A; Kuhn, D; Turos, E | 1 |
| Leibovici, L; Paul, M | 1 |
| Bliziotis, IA; Christodoulou, C; Chrysanthopoulou, S; Falagas, ME; Kasiakou, SK; Michalopoulos, A; Samonis, G | 1 |
| Ahmed, A; Chua, M; Chun, W; Hsueh, PR; Hussain, Y; Jootar, S; Jun, HX; Lee, DG; Lim, V; Lin, SF; Liu, CY; Liu, YC; Matsumoto, T; Ong, A; Picazo, JJ; Purushotaman, SV; Ranuhardy, D; Reksodiputro, AH; Suwangool, P; Tamura, K; Zhixiang, S | 1 |
| Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G | 1 |
| Durnaá, B; Dzierzanowska, D | 1 |
| Liu, R; Rao, J; Xing, B | 1 |
| Greene, WH | 1 |
| Bodey, GP; Bolivar, R; Elting, L; Estey, EH; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
| Gaus, W; Kern, WV; Kurrle, E; Moritz, T; Reichle, A; Rozdzinski, E; Schmeiser, T | 1 |
| Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H | 1 |
| DeJace, P; Klastersky, J | 1 |
12 review(s) available for beta-lactams and Neoplasms
| Article | Year |
|---|---|
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug-Related Side Effects and Adverse Reactions; Febrile Neutropenia; Humans; Neoplasms; Survival Analysis; Treatment Outcome | 2017 |
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cause of Death; Child; Combined Modality Therapy; Humans; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 2013 |
Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Databases, Factual; Drug Therapy, Combination; Febrile Neutropenia; Humans; Neoplasms; Randomized Controlled Trials as Topic | 2016 |
Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Critical Care; Critical Illness; Cystic Fibrosis; Fever; Humans; Infusions, Intravenous; Length of Stay; Leukocyte Count; Neoplasms; Respiration, Artificial; Treatment Outcome | 2012 |
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cause of Death; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 2003 |
Beta-lactams and their potential use as novel anticancer chemotherapeutics drugs.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; beta-Lactams; DNA; DNA Damage; Drug Design; Humans; Intercalating Agents; Neoplasms; Prodrugs; Radioimmunotherapy | 2004 |
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
[Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Drug Combinations; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia | 2006 |
Novel beta-lactam antibiotics derivatives: their new applications as gene reporters, antitumor prodrugs and enzyme inhibitors.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacterial Infections; beta-Lactams; Enzyme Inhibitors; Genes, Reporter; Humans; Models, Molecular; Molecular Probes; Molecular Structure; Neoplasms; Prodrugs; Stereoisomerism | 2008 |
The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Immunosuppression Therapy; Neoplasms; Neutropenia; Sepsis | 1984 |
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 2002 |
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1986 |
3 trial(s) available for beta-lactams and Neoplasms
| Article | Year |
|---|---|
Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Infant, Newborn; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Severity of Illness Index; Sulbactam | 2009 |
Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients.
Topics: Anemia, Aplastic; Anti-Bacterial Agents; beta-Lactams; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Netilmicin; Neutropenia; Prospective Studies | 1993 |
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1986 |
17 other study(ies) available for beta-lactams and Neoplasms
| Article | Year |
|---|---|
Chemical generation of bispecific antibodies.
Topics: Amino Acid Sequence; Angiopoietin-2; Animals; Antibodies, Bispecific; Antibody Specificity; Antineoplastic Agents; Azetidines; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Factors; Macaca fascicularis; Male; Mice; Mice, Nude; Molecular Sequence Data; Neoplasms; Protein Binding; Rats; Rats, Sprague-Dawley; Surface Plasmon Resonance; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2010 |
Insights into the anticancer activity of chiral alkylidene-β-lactams and alkylidene-γ-lactams: Synthesis and biological investigation.
Topics: Antineoplastic Agents; beta-Lactams; Cell Line; Humans; Lactams; Neoplasms | 2022 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis: authors' reply.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans; Neoplasms; Network Meta-Analysis | 2018 |
Three-component synthesis of chromeno β-lactam hybrids for inflammation and cancer screening.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzopyrans; beta-Lactams; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Inflammation; Mice; Molecular Structure; Neoplasms; RAW 264.7 Cells; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Aztreonam for febrile neutropenia in patients with beta-lactam allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Drug Hypersensitivity; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Neoplasms | 2014 |
Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Drug Utilization; Ertapenem; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Development of a combination antibiogram for Pseudomonas aeruginosa bacteremia in an oncology population.
Topics: Administration, Intravenous; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Medical Oncology; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2016 |
Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy.
Topics: Adolescent; Antineoplastic Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Infant; Infant, Newborn; Italy; Male; Neoplasms; Prospective Studies; Retrospective Studies; Survival Analysis | 2016 |
Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Australia; Bacteremia; Bacterial Infections; Bacteriological Techniques; beta-Lactams; Cancer Care Facilities; Disease Management; Drug Resistance, Multiple, Bacterial; Fever; Humans; Immunocompromised Host; Neoplasms; Neutropenia; Risk Assessment; Severity of Illness Index | 2011 |
Central venous catheter-associated Nocardia bacteremia in cancer patients.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Drug Therapy, Combination; Female; Humans; Male; Microscopy, Electron, Scanning; Neoplasms; Nocardia Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards.
Topics: Adolescent; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Cluster Analysis; Cross Infection; Czech Republic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Fluoroquinolones; Genotype; Hospitals, Pediatric; Humans; Multilocus Sequence Typing; Neoplasms; Plasmids | 2012 |
Systematic reviews and meta-analysis of febrile neutropenia.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Meta-Analysis as Topic; Neoplasms; Neutropenia; Reproducibility of Results; Review Literature as Topic; Treatment Outcome | 2005 |
Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Therapy, Combination; Fever of Unknown Origin; Guidelines as Topic; Humans; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2005 |
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 2006 |
Coagulation abnormalities induced by beta-lactam antibiotics in cancer patients.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Lactams; Blood Coagulation Disorders; Blood Coagulation Tests; Hemorrhage; Humans; Neoplasms | 1983 |
In vitro activity of ertapenem against bacterial isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Neoplasms; Staphylococcus; Streptococcus | 2002 |